|
Market Closed -
Other stock markets
|
After hours 04:38:16 pm | |||
| 248.08 USD | -0.73% |
|
246.10 | -0.80% |
| 01:04pm | Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says | MT |
| 10:23am | BofA Securities Adjusts AbbVie Price Target to $276 From $234 | MT |
Chart calendar AbbVie Inc.
Upcoming events on AbbVie Inc.
| 2026-07-15 | Ex-dividend date - 1.73 USD | 12:00 am |
| 2026-07-31 | Earnings presentation | 09:00 am |
| 2026-07-31 | Earnings release - Q2 2026 |
Past events on AbbVie Inc.
| 2026-05-08 | Présentation aux Actionnaires / Analystes | 10:00 am |
| 2026-05-08 | Annual General Meeting | 10:00 am |
| 2026-04-29 | Earnings presentation | 09:00 am |
| 2026-04-29 | Earnings release - Q1 2026 | |
| 2026-02-04 | Earnings release - Q4 2025 | |
| 2026-02-04 | Earnings presentation | 09:00 am |
| 2025-10-31 | Earnings release - Q3 2025 | |
| 2025-10-31 | Earnings presentation | 09:00 am |
| 2025-07-31 | Earnings presentation | 09:00 am |
| 2025-07-31 | Earnings release - Q2 2025 |
Past dividends on AbbVie Inc.
| 2026-04-15 | Ex-dividend date - 1.73 USD | 12:00 am |
| 2026-01-16 | Ex-dividend date - 1.73 USD | 12:00 am |
| 2025-10-15 | Ex-dividend date - 1.64 USD | 12:00 am |
| 2025-07-15 | Ex-dividend date - 1.64 USD | 12:00 am |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 54 318 54 047 0.5% | 56 334 56 043 0.52% | 61 160 60 957 0.33% | 67 235 | 72 734 | 78 132 |
|
EBITDA Million USD | Released Forecast Spread | 25 545 25 858 -1.21% | 24 104 23 980 0.52% | 24 483 24 611 -0.52% | 32 835 | 36 986 | 40 815 |
|
EBIT Million USD | Released Forecast Spread | 24 793 24 926 -0.53% | 23 340 23 323 0.07% | 23 721 23 906 -0.77% | 31 929 | 36 210 | 39 854 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 250 8 933 -30.04% | 3 716 10 308 -63.95% | 6 597 11 951 -44.8% | 15 746 | 21 842 | 25 794 |
|
Net income Million USD | Released Forecast Spread | 4 863 8 288 -41.32% | 4 278 3 826 11.8% | 4 226 7 425 -43.08% | 14 353 | 19 023 | 21 855 |
|
EPS USD | Released Forecast Spread | 2,72 5,30 -48.69% | 2,39 2,65 -9.64% | 2,36 3,58 -34.1% | 8,28 | 10,7 | 12,6 |
| Announcement Date | 02/02/24 | 31/01/25 | 04/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 14 460 14 277 1.28% | 15 102 14 827 1.86% | 13 343 12 921 3.27% | 15 423 15 030 2.61% | 15 776 15 586 1.22% | 16 618 16 415 1.24% | 15 002 14 719 1.93% | 16 758 | 17 294 | 18 137 | 15 900 | 18 085 | 18 663 | 19 313 |
|
EBITDA Million USD | Released Forecast Spread | 6 937 6 847 1.31% | 5 447 5 447 0% | 5 829 5 958 -2.16% | 7 019 6 755 3.91% | 5 073 4 864 4.29% | 6 562 6 434 1.99% | 6 315 6 246 1.11% | 8 444 | 8 970 | 8 837 | ||||
|
EBIT Million USD | Released Forecast Spread | 6 746 6 639 1.61% | 5 241 5 246 -0.09% | 5 648 5 499 2.7% | 6 833 6 615 3.3% | 4 881 5 094 -4.18% | 6 359 6 572 -3.24% | 6 127 6 140 -0.22% | 8 322 | 8 546 | 8 834 | 7 499 | 9 135 | 9 428 | 9 691 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 084 3 081 -32.36% | -2 269 3 000 -175.63% | 1 661 2 464 -32.59% | 1 554 3 517 -55.81% | 714 4 173 -82.89% | 2 668 4 223 -36.82% | 1 039 3 662 -71.63% | 5 342 | 4 876 | 4 992 | ||||
|
Net income Million USD | Released Forecast Spread | 1 561 2 093 -25.42% | -22,0 -869 97.47% | 1 286 1 778 -27.69% | 938 1 891 -50.41% | 186 -1 149 116.19% | 1 816 5 088 -64.31% | 695 2 827 -75.42% | 4 279 | 4 287 | 4 448 | 3 392 | 5 003 | 5 386 | 5 712 |
|
EPS USD | Released Forecast Spread | 0,88 1,44 -38.72% | -0,02 -0,50 95.96% | 0,72 0,29 145.77% | 0,52 1,17 -55.61% | 0,10 -1,19 108.4% | 1,02 2,87 -64.51% | 0,39 1,25 -68.9% | 2,14 | 2,28 | 2,79 | 1,92 | 2,82 | 3,04 | 3,23 |
| Announcement Date | 30/10/24 | 31/01/25 | 25/04/25 | 31/07/25 | 31/10/25 | 04/02/26 | 29/04/26 | - | - | - | - | - | - | - |
| 2026-07-13 |  | Ex-dividend date - 0.77711 EUR | 12:00 am |
| 2026-07-15 | | Earnings release - Q2 2026 | 06:45 am |
| 2026-07-15 | | Earnings presentation | 08:30 am |
| 2026-07-15 | | Earnings release - Q2 2026 | |
| 2026-07-15 | | Earnings presentation | 08:00 am |
| 2026-07-15 | | Extraordinary General Meeting | 02:30 am |
| 2026-07-16 | | Extraordinary General Meeting | 02:00 am |
| 2026-07-16 | | Extraordinary General Meeting | 02:30 am |
| 2026-07-17 | | Ex-dividend date - 18 INR | 12:00 am |
| 2026-07-17 | | Earnings release - Q2 2026 |
Past sector events for AbbVie Inc.
| Today | | Ex-dividend date - 8 INR | 12:00 am |
| Today | | Extraordinary General Meeting | 02:00 am |
| Today | | Extraordinary General Meeting | 02:00 am |
| Today | | Ex-dividend date - 0.17248 HKD | 12:00 am |
| Today | | Annual General Meeting | 01:30 am |
| Today | | Présentation aux Actionnaires / Analystes | 01:30 am |
| 2026-07-09 | | Information meeting | 07:00 am |
| 2026-07-09 | | Earnings presentation | 02:00 am |
| 2026-07-09 | | Ex-dividend date - 0.15 CNY | 12:00 am |
| 2026-07-09 | | Ex-dividend date - 0.28 CNY | 12:00 am |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
- Calendar AbbVie Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
